Suppr超能文献

一种安全有效的小麦口服免疫疗法

A Safe and Effective Method for Wheat Oral Immunotherapy.

作者信息

Khayatzadeh Alireza, Gharaghozlou Mohamad, Ebisawa Motohiro, Shokouhi Shoormasti Raheleh, Movahedi Masoud

机构信息

Department of Allergy and Clinical Immunology, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

Department of  Department of Allergy, Clinical Research Center for Allergy and Rheumatology Sagamihara National Hospital, Sagamihara, Japan.

出版信息

Iran J Allergy Asthma Immunol. 2016 Dec;15(6):525-535.

Abstract

At present the only available management for food allergy is avoidance; however, abstaining from allergic foods can affect the quality of life. Oral Immunotherapy (OIT) is an efficient method for increasing tolerance towards food allergens. The aim of this study was desensitizing patients above five years of age with wheat allergy and evaluating the safety and efficacy of OIT for children with IgE-mediated wheat allergy. The method of Rush Oral Immunotherapy (ROIT) was performed on 8 anaphylactic wheat allergic patients as well as outpatient method on 5 non-anaphylactic ones. In ROIT, build-up phase was performed during several days, but in outpatient, the amount of ingestion gradually increased to 5.2 g wheat protein within several weeks. After that, maintenance doses were prescribed daily for 3 months. Then, if the oral food challenge (OFC) was negative, the patients were considered to be in desensitized state, which meant they had to continue eating same doses without interruption. In ROIT, build-up phase continued for about 4.6 days during which, 21 from 71 doses, showed clinical symptoms (29.6%). On the contrary, outpatient method lasted approximately 72.4 days in which 356 doses were used and symptoms developed in only 9 doses (2.5%). In total -regardless of type of build-up phase- 12 patients could complete the maintenance phase with 1080 doses that 28 of them (2.6%) developed mild symptoms. Our OIT study proved to be safe and effective, although it is utterly evident that further investigation on more patients is necessary.

摘要

目前,食物过敏唯一可行的管理方法是避免接触;然而,禁食过敏食物会影响生活质量。口服免疫疗法(OIT)是一种提高对食物过敏原耐受性的有效方法。本研究的目的是使五岁以上的小麦过敏患者脱敏,并评估OIT对IgE介导的小麦过敏儿童的安全性和有效性。对8名过敏性小麦过敏患者采用快速口服免疫疗法(ROIT),对5名非过敏性患者采用门诊治疗方法。在ROIT中,递增阶段在几天内完成,但在门诊治疗中,摄入量在几周内逐渐增加到5.2克小麦蛋白。之后,每天开维持剂量,持续3个月。然后,如果口服食物激发试验(OFC)为阴性,则患者被认为处于脱敏状态,这意味着他们必须持续不间断地食用相同剂量。在ROIT中,递增阶段持续约4.6天,在此期间,71剂中有21剂出现临床症状(29.6%)。相反,门诊治疗方法持续约72.4天,使用了356剂,仅9剂出现症状(2.5%)。总体而言——无论递增阶段的类型如何——12名患者能够完成维持阶段,共服用1080剂,其中28剂(2.6%)出现轻微症状。我们的OIT研究被证明是安全有效的,尽管显然有必要对更多患者进行进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验